| Autor: |
Koch LM; Institute of Biochemistry, Department of Biology, ETH Zurich, Zurich, Switzerland.; Life science Zürich, PhD program for Molecular Life Sciences, Zurich, Switzerland., Birkeland ES; Institute of Biochemistry, Department of Biology, ETH Zurich, Zurich, Switzerland.; Life science Zürich, PhD program for Molecular Life Sciences, Zurich, Switzerland., Battaglioni S; Institute of Biochemistry, Department of Biology, ETH Zurich, Zurich, Switzerland.; Biozentrum, University of Basel, Basel, Switzerland., Helle X; Institute of Biochemistry, Department of Biology, ETH Zurich, Zurich, Switzerland., Meerang M; Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland., Hiltbrunner S; Department of Medical Oncology and Hematology, University Hospital Zurich, Comprehensive Cancer Center Zurich, University of Zurich, Zurich, Switzerland., Ibáñez AJ; Core facility for Omics Research and Applied Biotechnology (ICOBA), Pontificia Universidad Católica del Perú, Lima, Peru., Peter M; Institute of Biochemistry, Department of Biology, ETH Zurich, Zurich, Switzerland., Curioni-Fontecedro A; Department of Medical Oncology and Hematology, University Hospital Zurich, Comprehensive Cancer Center Zurich, University of Zurich, Zurich, Switzerland., Opitz I; Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland., Dechant R; Institute of Biochemistry, Department of Biology, ETH Zurich, Zurich, Switzerland. reinhard.dechant@bc.biol.ethz.ch. |
| Abstrakt: |
Enhanced growth and proliferation of cancer cells are accompanied by profound changes in cellular metabolism. These metabolic changes are also common under physiological conditions, and include increased glucose fermentation accompanied by elevated cytosolic pH (pHc) 1,2 . However, how these changes contribute to enhanced cell growth and proliferation is unclear. Here, we show that elevated pHc specifically orchestrates an E2F-dependent transcriptional programme to drive cell proliferation by promoting cyclin D1 expression. pHc-dependent transcription of cyclin D1 requires the transcription factors CREB1, ATF1 and ETS1, and the histone acetyltransferases p300 and CBP. Biochemical characterization revealed that the CREB1-p300/CBP interaction acts as a pH sensor and coincidence detector, integrating different mitotic signals to regulate cyclin D1 transcription. We also show that elevated pHc contributes to increased cyclin D1 expression in malignant pleural mesotheliomas (MPMs), and renders these cells hypersensitive to pharmacological reduction of pHc. Taken together, these data demonstrate that elevated pHc is a critical cellular signal regulating G1 progression, and provide a mechanism linking elevated pHc to oncogenic activation of cyclin D1 in MPMs, and possibly other cyclin D1~dependent tumours. Thus, an increase of pHc may represent a functionally important, early event in the aetiology of cancer that is amenable to therapeutic intervention. |
Full text from SpringerLink